Welcome to our dedicated page for Pineapple news (Ticker: PNPL), a resource for investors and traders seeking the latest updates and insights on Pineapple stock.
Pineapple, Inc. (PNPL) reports developments around a non-plant-touching cannabis business model, including leases and subleases to licensed cannabis retailers, cannabis business management, licensing and consulting services, and online and in-store hemp-derived CBD transactions. Company updates have also covered Pineapple Wellness, ShroomTropics functional mushroom products, and branded intellectual-property assets such as domains, trademarks and a patent.
Corporate news for PNPL includes its completed name change from Pineapple Express, Inc. to Pineapple, Inc., its domicile change to Nevada, OTC market status, and its Form 15 filing to voluntarily terminate SEC reporting obligations. Coverage also reflects management updates on cannabis retail property activity in the Los Angeles market.
Pineapple Inc. (OTC: PNPL) has announced plans to launch the Pineapple Express Token, a real-world asset-backed cryptocurrency built on the Solana blockchain, in Q3 2025. The token will be backed by the company's intellectual property portfolio, including domains, trademarks, patents, and management contracts.
The initiative aims to generate recurring royalties through commercial utilization of IP assets via blockchain-based smart contracts. PNPL shareholders will be eligible to receive tokens at no cost by verifying their stock ownership. The token will be supported by various assets including the pineappleexpress.com domain, U.S. Patent No. 9,642,476, and multiple registered trademarks.
The Los Angeles-based company operates in cannabis management, functional mushroom supplements, and CBD wellness products through its subsidiary Pineapple Wellness, Inc.Pineapple Inc. (OTC: PNPL) has announced its strategic expansion into two new business segments: functional mushroom products and cannabis retail management. The company launched Shroomtropics, a new line of functional mushroom supplements available in three varieties: Relax, Mind & Body, and Performance, offered in gummy form at select retailers.
The company is also entering the cannabis retail management sector, overseeing existing management contracts in the Los Angeles market. This includes supporting Pineapple Consolidated Inc.'s expansion, which operates the Pineapple Express Hollywood dispensary and plans to launch four new locations.
Pineapple Inc.'s business portfolio includes:
- Property procurement and leasing for licensed cannabis operators
- Cannabis business management services
- Functional mushroom supplements through shroomtropics.com
- Hemp-derived CBD products via pineapplewellness.com
- Cannabis business licensing and consulting services through Pineapple Express Consulting
Pineapple Inc. has updated shareholders on recent developments, announcing the filing of a Form 15 with the SEC to terminate duty to file reports due to issues with its 2022 audit firm. The company will be following the OTC Markets Alternative Reporting standard until new audits are filed in a Form 10 with the SEC. Chairman Matthew Feinstein expressed the company's commitment to financial transparency.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Pineapple, Inc. (OTC Pink: PNPL), a legal cannabis industry company, has announced a delay in filing its 2022 Annual Report on Form 10-K due to recent changes in its business operations. This delay follows the divestment of an asset with direct plant-touching activities and is essential to ensure the accuracy of the financial information presented. The company is finalizing the Annual Report, which it plans to submit in the coming weeks, followed by the 2023 quarterly report. Chairman Matthew Feinstein emphasized the importance of thorough review during the OTC Markets Group transition to an elevated tier. CEO Shawn Credle acknowledged the patience of shareholders during this process, highlighting the company's dedication to transparency and accuracy.